Healthcare >> Analyst Interviews >> August 7, 2000
Carol Werther is a Senior Analyst in Biotechnology at Summer Street Research
Partners. Prior to joining the company, she worked as a biotechnology consultant
for several firms, including Winslow Management and Rx Capital. She has also
held senior biotechnology analyst positions at Think Equity and Adams Harkness &
Hill. She was recognized by The Wall Street Journal's "Best on the Street
Survey" in 2000 and 2001. She received an MBA degree from New York University,
Stern School of Business, and holds an MS degree and a BS degree in Nutrition
Sciences from the University of Alabama in Birmingham and Cornell University,
respectively. Profile
& Hill take to investing in biotechnology?
Ms. Werther: The primary objective at Adams is to provide
